Articles

Correlation of clinical response and response duration with miR-145 induction by lenalidomide in CD34+ cells from patients with del(5q) myelodysplastic syndrome

Leukemia/Bone Marrow Transplant Program, Division of Hematology, University of British Columbia, Vancouver, BC, Canada
British Columbia Cancer Research Centre, Vancouver, BC, Canada
Leukemia/Bone Marrow Transplant Program, Division of Hematology, University of British Columbia, Vancouver, BC, Canada
Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA, USA
H. Lee Moffitt Cancer Center, Tampa, FL, USA
Universitätsklinikum “Carl-Gustav-Carus”, Medizinische Klinik I, Dresden, Germany
Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA, USA
H. Lee Moffitt Cancer Center, Tampa, FL, USA
Universitätsklinikum “Carl-Gustav-Carus”, Medizinische Klinik I, Dresden, Germany
H. Lee Moffitt Cancer Center, Tampa, FL, USA
British Columbia Cancer Research Centre, Vancouver, BC, Canada
Vol. 98 No. 3 (2013): March, 2013 https://doi.org/10.3324/haematol.2012.066068